Deep Genomics
Best for biotech
AI-driven drug discovery
Advanced genomic research
Enterprise solution
RNA therapy focus
Programming RNA Therapies for Any Gene, Any Genetic Condition
Last updated: Apr 15, 2026
ENTERPRISE
deepgenomics.com
Quick Answer
Deep Genomics is an AI-driven genetic medicine company that programs RNA therapies for various genetic conditions. Its proprietary AI platform analyzes complex RNA biology, identifies novel targets, and evaluates therapeutic candidates. Best for pharmaceutical and biotech companies seeking to accelerate drug discovery. Pricing is enterprise-level.
About Deep Genomics
Deep Genomics provides an AI platform for drug development, leveraging AI, RNA biology, and automation to program RNA therapies. It untangles complex RNA biology, identifies novel targets, and evaluates therapeutic candidates to address genetic conditions. The platform is designed for data-driven prediction and exponential growth in drug discovery.
What Makes It Unique
Deep Genomics developed the first Foundation Model for RNA Biology, BigRNA, and is advancing to BigRNA+ to expand mechanisms and genetic variants for complex disease modulation.
Use Cases & Target Users
Use Cases
Best For
Developing RNA therapies for genetic conditions
Accelerating drug discovery with AI
Untangling complex RNA biology data
Identifying novel therapeutic targets
Company Size
ENTERPRISE
Fit Score
Complexity
ADVANCED
Target Team Size
LARGE_TEAM
Target Skill Level
EXPERT
Key Features
AI-powered RNA biology analysis
Novel target identification
Therapeutic candidate evaluation
Data-driven prediction for drug development
Foundation Model for RNA Biology (BigRNA)
Expansion into complex genetic diseases (BigRNA+)
Technical Specifications
API Available
SDK Available
MCP Compatible
Open Source
Team Features
SSO/Enterprise
Webhook Support
Has Demo
Deployment:
CLOUD
Pros
- +Leverages cutting-edge AI and RNA biology
- +Proprietary AI platform for data-driven prediction
- +Addresses a wide range of genetic conditions
- +Founded by internationally acclaimed scientists in deep learning and genomics
Limitations
- -Highly specialized for genetic medicine and RNA therapies
- -Requires deep scientific and technical expertise
- -No public pricing or direct access for individuals
- -Focus on early-stage drug discovery, not clinical trials
Powered By
Base Models
BigRNA
Uses Models
BigRNABigRNA+
Decision Intelligence
Best For
Developing RNA therapies for genetic conditions
Accelerating drug discovery with AI
Untangling complex RNA biology data
Identifying novel therapeutic targets
Not Ideal For
General AI research or development
Non-biotech or pharmaceutical companies
Individuals seeking direct medical treatment
Small-scale academic research without significant funding
Frequently Asked Questions
Your Actions
Dimension Scores
Ease of Use2/10
Output Quality8/10
Value for Money7/10
Customization2/10
Support6/10
Integration1/10
Task Scores
Research Analysis
9
Diagnosis Support
7
Clinical Documentation
2
Compliance Tracking
2
Patient Communication
1
Drug Interaction Check
1
Health Monitoring
1
Appointment Management
1
Trust Score
35/100
Limited Data
Based on 4 verified signals
Trust Signals
Verified CompanyDeep Genomics
Funding$236.7 million
Team Size51-200
Data Residency
Switching & Migration
Migration Difficulty
Significant Effort
Email only
Quick Stats